Skip to main content

Advertisement

SpringerLink
Log in

Is late stent thrombosis in drug-eluting stents a real clinical issue?

A single-center experience and review of the literature

  • ORIGINAL PAPER
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Summary

Background

Randomized studies have not found an increased rate of late stent thrombosis (LAST) in drug-eluting stents (DES) compared with bare metal stents (BMS) but those studies were statistically not powered to show such a difference. At the same time there is an increasing number of reports of LAST in DES patients in the current literature.

Patients and methods

We tried to describe the incidence of LAST in an unselected DES and BMS patient population. All patients who underwent stenting in our hospital between October 2003 and March 2006 were included in the study (n=1377). A total of 424 (30.1%) patients were treated with only BMS stents, 520 (37.8%) with paclitaxel-eluting stents (PES), 384 (27.9%) with sirolimus-eluting stents (SES) and 49 (3.6%) with BMS and DES. Long-term follow-up of all patients was used to determine the incidence of LAST as defined by angiographically proven stent thrombosis associated with acute symptoms more than 30 days after stent implantation. Followup was between 1 month and 2 years 7 months (mean 12 months). Patients treated with DES were younger (66±11 years) than BMS patients (72±10 years; p<0.001) and more often had diabetes (24.2% vs 17.4%; p < 0.001). A previous PCI had been performed in 27.1% of DES patients vs 13.9% of BMS patients (p < 0.001).

Results

There were 9 cases of LAST: 2 with SES (at 6 and 11 months after implantation), 6 with PES (at 6, 9 (2×), 10, 16 and 26 months), and one with BMS (at 22 months). All patients with LAST presented with STEMI and without an angina history that suggested restenosis. Two cases were related to complete cessation of antiplatelet therapy, one because of patient non-compliance (SES), one after aspirin was stopped for orthopedic surgery (BMS). Two cases occurred within 1 month of cessation of clopidogrel therapy and while these patients were on aspirin therapy. Five cases occurred on aspirin monotherapy 2, 3, 4, 10 and 20 months, respectively after planned cessation of clopidogrel. None of the cases occurred under dual antiplatelet therapy. All patients underwent primary PCI; none died.

Conclusion

Angiografically proven LAST occurred in our unselected patient population with an incidence of 0.84% in patients treated with DES and 0.21% in BMS patients within a mean follow-up of 12 months (p = 0.36). LAST may indeed occur in clinically stable patients while on aspirin monotherapy. Since LAST led in all patients to STEMI it seems to be a serious clinical issue that prompts further investigation and discussion of length of dual platelet therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW, for the Taxus II study group (2005) Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112:3876–3883

    Article  PubMed  CAS  Google Scholar 

  2. Azarbal B, Currier JW (2006) Allergic reactions after the implantation of drug-eluting stents. Is is the pill or the polymer? J Am Coll Cardiol 47:182–183

    Article  PubMed  Google Scholar 

  3. Babapulle MN, Joseph L, Bélisle P, Brophy JM, Eisenberg MJ (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drugeluting stents. Lancet 364:583–591

    Article  PubMed  CAS  Google Scholar 

  4. Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL (2005) What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. J Am Coll Cardiol 45:941–946

    Article  PubMed  Google Scholar 

  5. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL (2006) Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151:1260–1264

    Article  PubMed  Google Scholar 

  6. Colombo A, Corbett SJ (2006) Drugeluting stent thrombosis. Increasingly recognized but too frequently overemphasized. J Am Coll Cardiol 48:203–205

    Article  PubMed  Google Scholar 

  7. Decoene C, Vincentelli A, Fabre O, Crepin F, Pol A (2005) Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation. Ann Fr Anesth Reanim 24:1275–1277

    Article  PubMed  CAS  Google Scholar 

  8. Desmet W (2006) Delayed neointimal healing after drug-eluting stent implantation: seeing is believing. Eur Heart J 27:2147–2149

    Article  PubMed  CAS  Google Scholar 

  9. Eisenberg MJ (2004) Drug-eluting stents: some bare facts. Lancet 364:1466–1467

    Article  PubMed  CAS  Google Scholar 

  10. Feres F, Costa JR Jr, Abizaid A (2006) Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 68:83–88

    Article  PubMed  Google Scholar 

  11. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45:995–998

    Article  PubMed  CAS  Google Scholar 

  12. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130

    Article  PubMed  CAS  Google Scholar 

  13. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skoija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202

    Article  PubMed  Google Scholar 

  14. Kang WC, Han SH, Choi KR, Ahn TH, Shin EK (2005) Acute myocardial infarction caused by late stent thrombosis after deployment of a paclitaxel- eluting stent. J Invasive Cardiol 17:378–380

    PubMed  Google Scholar 

  15. Kammler J, Hofmann R, Steinwender C, Kypta A, Leisch F (2006) Simultaneous angiographic late stent thrombosis in two different coronary vessels after withdrawal of the combined anti-platelet therapy. Clin Res Cardiol; published online august 16, 2006

  16. Klutmann M, Tillmanns C, Gulba DC (2006) Postoperative antithrombotische Therapie bei diabetischen Patienten. Clin Res Cardiol 95(Suppl 1):I/74–I/77

    Article  Google Scholar 

  17. Kotani JI, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S (2006) Incomplete neointimal coverage of sirolimus- eluting stents. J Am Coll Cardiol 47:2108–2111

    Article  PubMed  CAS  Google Scholar 

  18. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113:1108–1113

    Article  PubMed  CAS  Google Scholar 

  19. Lee CH, Lim J, Low A, Tan HC, Lim YT (2006) Late angiographic stent thrombosis of polymer based paclitaxel eluting stent. Heart 92:551–553

    Article  PubMed  CAS  Google Scholar 

  20. Manjappa N, Agarwal A, Cavusoglu E (2006) Very late bare-metal stent thrombosis. A case report and review of the literature. J Invasive Cardiol 18:E203–E206

    PubMed  Google Scholar 

  21. McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519– 1521

    Article  PubMed  CAS  Google Scholar 

  22. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, Banuelos C, Fernandez-Ortiz A, Macaya C (2005) Drug-eluting stent thrombosis: results from a polled analysis including 10 randomized studies. J Am Coll Cardiol 45:954–959

    Article  PubMed  CAS  Google Scholar 

  23. Motz W, Kaiser R (2006) Stenttherapie bei diabeteskranken Patienten. Clin Res Cardiol 95(Suppl 1):I/27–I/30

    Article  Google Scholar 

  24. Nebeker JR, Virmani R, Bennett CL, Hoffmann JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD (2006) Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 47:175–181

    Article  PubMed  Google Scholar 

  25. Nilsen DW, Melberg T, Larsen AI, Barvik S, Bonarjee V (2005) Late complications following the deployment of drug eluting stents. Int J Cardiol 109:398–401

    Article  PubMed  Google Scholar 

  26. Nilsson T, Albertsson P, James S, Olsson H, Lagerqvist B. Scaar. Årsrapport 2004. http://www.ucr.uu.se/scaar/ arsrapporter/SCAAR_report_2004.pdf, accessed 28.11.2006

  27. Olivier AC, Hollman JL (2006) Late in-stent thrombosis in a patient with systemic lupus erythematodes and hyperhomocysteinemia while on clopidogrel and aspirin. J Invasive Cardiol 18:E185–E187

    PubMed  Google Scholar 

  28. Ong ATL, Hoye A, Aoki J, van Miegham CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PPT, de Feyter P, van Domburg RT, Serruys PW (2005) Thirtyday incidence and six-months clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45:947–953

    Article  PubMed  CAS  Google Scholar 

  29. Ong ATL, McFadden EP, Regar E, de Jaegere PPT, van Domburg RT, Serruys PW (2005) Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45:2088–2092

    Article  PubMed  CAS  Google Scholar 

  30. Ong ATL, van Domburg RT, Aoki J, Sonnenschein K, Lemos PA, Serruys PW (2006) Sirolimus-eluting stents remain superior to bare-metal stents at two years. Medium-term results from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. J Am Coll Cardiol 47:1356–1360

    Article  PubMed  CAS  Google Scholar 

  31. Pasceri V, Pelliccia F, Cianfrocca C, Pristipino C, Santini M, Richichi G (2006) Very late thrombosis after sirolimus- eluting stent implantation. J Cardiovasc Med 7:438–442

    Article  Google Scholar 

  32. Pfisterer ME (2006) Presentation of the results of the Basel Stent Cost-effectiveness Trial – Late thrombotic events (BASKET-LATE). 55th Annual Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 14, 2006

  33. Schampaert E, Moses JW, Schofer J, Schlueter M, Gershlick AH, Cohen EA, Palisaitis DA, Breithardt G, Donohoe DJ, Wang H, Popma JJ, Kuntz RE, Leon MB, for the Sirius, E- and C-Sirius investigators (2006) Sirolimus- eluting stents at two years: a pooled analysis of Sirius, E-Sirius, and C-Sirius with emphasis on late revascularizations and stent thromboses. Am J Cardiol 98:36–41

    Article  PubMed  CAS  Google Scholar 

  34. Sigwart U (2006) Drug-eluting stents are safe and effective. Right or wrong? J Am Coll Cardiol 47:1361–1362

    Article  PubMed  Google Scholar 

  35. Skyttberg N, Linder R, Carlsson J (2006) Increased risk for late stent thrombosis using drug eluting stents. Läkartidningen 103:2845–2847

    PubMed  Google Scholar 

  36. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Results from the Premier registry. Circulation 113:2803–2809

    Article  PubMed  CAS  Google Scholar 

  37. Stabile E, Cheneau E, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R (2004) Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy. Cardiovasc Radiat Med 5:173–176

    Article  PubMed  Google Scholar 

  38. Takano M, Mizuno K (2006) Late coronary thrombosis in a sirolimus-eluting stent due to lack of neointimal coverage. Eur Heart J 27:1133

    Article  PubMed  Google Scholar 

  39. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K (2006) Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 27:2189–2195

    Article  PubMed  CAS  Google Scholar 

  40. Tsimikas S (2006) Drug-eluting stents and late adverse clinical outcomes. Lessons learned, lessons awaited. J Am Coll Cardiol 47:2112–2115

    Article  PubMed  CAS  Google Scholar 

  41. Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll HP, on behalf of the e-Cypher Investigators (2006) Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow- up of the e-Cypher registry. Circulation 113:1434–1441

    Article  PubMed  CAS  Google Scholar 

  42. Virmani R, Farb A, Guagliumi G, Kolodgie FD (2004) Drug-eluting stents: caution and concerns for long-term outcome. Coronary Artery Disease 15:313–318

    Article  PubMed  Google Scholar 

  43. Waksman R, Ajani AE, White RL, Pinnow E, Dieble R, Bui AB, Taaffe M, Gruberg L, Mintz GS, Satler LF, Pichard AD, Kent KK, Lindsay L (2001) Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gammaradiation in patients with in-stent restenosis: Washington radiation for in-stent restenosis trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 103:2332–2335

    PubMed  CAS  Google Scholar 

  44. Wang F, Stouffer GA, Waxman S, Uretsky BF (2002) Late coronary stent thrombosis: early vs late stent thrombosis in the stent era. Catheter Cardiovasc Interv 55:142–147

    Article  PubMed  Google Scholar 

  45. Wang TH, Bhatt DL, Topol EJ (2006) Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 27:647–654

    Article  PubMed  CAS  Google Scholar 

  46. Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH Jr (2005) Late thrombosis following treatment of in-stent restenos with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 65:520–524

    Article  PubMed  Google Scholar 

  47. Weisz G, Leon MB, Holmes DR, Kereiakes DJ, Clark MR, Cohen BM, Ellis SG, Coleman P, Hill C, Shi C, Cutlip DE, Kuntz RE, Moses JW (2006) Twoyear outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol 47:1350–1355

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Cardiology, Länssjukhuset i Kalmar, Lasarettsvägen, 39185, Kalmar, Sweden

    Jörg Carlsson MD, FESC, Burhard von Wagenheim, Tahir M. Anwari, Jeanette Qvist, Iren Petersson & Theo Magounakis

  2. Medicinkliniken, Capio S:t Görans Sjukhus, Stockholm, Sweden

    Rikard Linder

  3. Department of Cardiology, Akademiska University Hospital, Uppsala, Sweden

    Bo Lagerqvist

Authors
  1. Jörg Carlsson MD, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burhard von Wagenheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rikard Linder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tahir M. Anwari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeanette Qvist
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Iren Petersson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Theo Magounakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bo Lagerqvist
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jörg Carlsson MD, FESC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlsson, J., von Wagenheim, B., Linder, R. et al. Is late stent thrombosis in drug-eluting stents a real clinical issue?. Clin Res Cardiol 96, 86–93 (2007). https://doi.org/10.1007/s00392-007-0464-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-007-0464-x

Key words

Search

Navigation